Opioid Overdose Is Not Sleep. It Can Be a Brain Injury Event
Sleep, anesthesia, coma, and opioid overdose have less in common than you think.
Posted June 1, 2026 | Reviewed by Gary Drevitch
Many of the drugs used in operating rooms are the same or close pharmacologic relatives to drugs involved in overdose deaths. Fentanyl changed the opioid epidemic, making opioid, cocaine, and other drug use deadly, but fentanyl remains a cornerstone of modern anesthesia. The difference lies in self-administration, dosing, monitoring, airway management , oxygen delivery, and the presence of trained professionals prepared to intervene the moment breathing becomes compromised. But individuals addicted to opioids receive none of these protections. The risk of dying from general anesthesia is extremely low—roughly 1 in 200,000 cases. Hundreds die of drug overdoses, but 60,000 patients safely receive general anesthesia for procedures every day in the United States.
A new study from investigators at Yale School of Medicine has renewed scientific debate about what happens to the brain during unconsciousness. This study demonstrated that propofol anesthesia generates electroencephalographic features resembling both sleep and coma, while also displaying brain activity unique to anesthesia. The authors argued that the traditional “sleep versus coma” framework is too simplistic. General anesthesia, they suggested, is neither fully sleep-like nor fully coma-like. Instead, it’s a distinct neurophysiologic state with overlapping features of both.
The Yale findings built on earlier work by anesthesiologist and neuroscientist Emery N. Brown and colleagues, who proposed that general anesthesia was best understood as a reversible drug-induced coma. Brown’s central insight was that anesthetic drugs do not “turn off” the brain. Instead, they impose highly structured oscillatory activity that disrupts communication among the cortical and thalamocortical networks, necessary for consciousness.
Sleep, anesthesia, coma, opioid intoxication, and overdose all may involve reduced consciousness and responsiveness, but each state arises through profoundly different mechanisms, carrying very different consequences for the brain and body.
That distinction is critical in the fentanyl era, when the public often mistakes opioid-induced “nodding” for ordinary falling asleep.
Some anesthetic states appear partly sleep-like, and others more coma-like, while still retaining anesthesia-specific electrophysiologic signatures. At the same time, none of these states is directly comparable to opioid overdose, a whole other ballgame.
Often, a person using opioids may appear to be nodding off to sleep when, instead, they may be lapsing into serious oxygen deprivation. Humans interpret closed eyes, reduced movement, and diminished responsiveness as sleep. Opioid intoxication exploits those visual cues. A person experiencing dangerous respiratory depression may appear merely tired, even while oxygen levels are falling to life-threatening hypoxic levels. Sleep evolved to support restoration, memory consolidation, metabolic regulation, and brain health. Opioid-induced hypoxia does the opposite, disrupting cellular metabolism, injuring vulnerable neurons, and impairing the very cognitive functions that healthy sleep helps preserve.
Opioid overdose differs fundamentally from sleep or anesthetic sedation because the central danger is not unconsciousness but oxygen deprivation to the brain.
A patient under general anesthesia is continuously monitored by experts. Oxygen delivery is maintained. Ventilation is supported. Any airway obstruction is rapidly corrected. Although anesthetic drugs profoundly alter consciousness, modern anesthesia is specifically designed to avoid hypoxic brain injury. In contrast, the person nodding off from opioid abuse on a sidewalk, in a parked car, or in a public restroom has none of those protections.
In overdose, the brain injury often comes not from unconsciousness, but from prolonged hypoxia during respiratory depression. Although the individual may appear peacefully asleep, the brain may be cycling through episodes of metabolic stress , brain injury, and intermittent oxygen starvation.
Illicit opioids suppress respiratory centers in the brainstem, including the rhythm-generating circuits necessary for automatic breathing. As respirations slow, oxygen levels fall, and carbon dioxide rises. The brain becomes vulnerable to hypoxic injury. Neurons involved in memory, judgment, emotional regulation , executive functioning , and motor control are particularly sensitive to oxygen deprivation.
A person using heroin, fentanyl, morphine, or other opioids drifts in and out of consciousness. The head "nods" or drops forward. The body slumps. Seconds later, the person may jerk awake, speak briefly, and then sink back into sedation. To the untrained observer, this may look like falling asleep. But opioid-induced nodding is unstable pharmacologic sedation accompanied by impaired arousal and compromised respiratory control.
Pinpoint pupils, slumped posture, slow or irregular breathing, gurgling respirations, cyanosis (bluish skin), and inability to awaken are not signs of restorative rest. They are warning signs of a medical emergency. Call 911, administer naloxone (Narcan), provide rescue breathing when appropriate, and seek immediate medical assistance.
The fentanyl era has further intensified brain injury dangers. Fentanyl and its analogs can produce rapid, profound respiratory depression. The transition from nodding to fatal overdose may occur gradually or abruptly, especially since illicit drug potency is unpredictable. Bystanders may mistakenly assume an individual is “ sleeping it off,” and delay or forego naloxone administration, rescue breathing, and emergency intervention.
Repeated overdose episodes may cause some cognitive and emotional difficulties that patients complain of in recovery. Survivors may experience memory impairment, slowed thinking, poor concentration , executive dysfunction, mood instability, impulsivity, or difficulty regulating emotions. These symptoms are often attributed to addiction , trauma , depression, or withdrawal. Those factors matter, but recurrent hypoxic injury may also contribute substantially to these problems. Prolonged hypoxia can produce diffuse brain injury affecting cortical and subcortical regions alike.
Overdose Is Not Sleep or Anesthesia
Although these states can look superficially similar, sleep restores the brain, and anesthesia temporarily reorganizes brain networks under carefully controlled conditions. Opioid overdose threatens the brain through oxygen deprivation. Overdose is not only a poisoning event; it can be a brain-injury event. Recovery is therefore not only about stopping drug use. Time is of the essence in protecting and rehabilitating the brain.
Understanding opioid nodding as neither sleep nor anesthesia also helps reduce stigma while increasing the urgency to help the person. The person unconscious from opioids and slumped forward is not lazy, morally defective, or simply resting. They may be in a fragile physiologic state between sedation and death. They need recognition, oxygen, naloxone when indicated, and access to evidence-based addiction treatment.
Fortunately, recovery remains possible. The brain retains meaningful capacity for repair and adaptation. Sustained abstinence or effective medication treatment, prevention of further overdoses, improved sleep, nutrition , exercise, psychiatric care, social connection, cognitive rehabilitation, and treatment of co-occurring conditions can all support neurologic recovery. The most important neurologic intervention may simply be preventing the next hypoxic episode.
The public health message should be clear: Don’t confuse nodding with sleep, and do not confuse overdose with anesthesia. Opioid-induced respiratory depression can damage oxygen-sensitive brain cells, produce lasting cognitive and emotional impairment, and cause death. Recognizing this reality should strengthen prevention efforts, naloxone distribution, rescue-breathing education , treatment access, and long-term recovery support.
Helfrich JD, Szaflarski J, Nævra MCJ, Romunstad L, Walker MP, Mander BA, Knight RT, Larsson PG, Helfrich RF. Spectral mapping reveals a resemblance of the anesthetic brain state to both sleep and coma. Proc Natl Acad Sci U S A. 2026 May 26;123(21):e2514098123. doi: 10.1073/pnas.2514098123. Epub 2026 May 11. PMID: 42114012.
Brown EN, Lydic R, Schiff ND. General anesthesia, sleep, and coma. N Engl J Med. 2010 Dec 30;363(27):2638-50. doi: 10.1056/NEJMra0808281. PMID: 21190458; PMCID: PMC3162622.
Purdon PL, Pierce ET, Mukamel EA, Prerau MJ, Walsh JL, Wong KF, Salazar-Gomez AF, Harrell PG, Sampson AL, Cimenser A, Ching S, Kopell NJ, Tavares-Stoeckel C, Habeeb K, Merhar R, Brown EN. Electroencephalogram signatures of loss and recovery of consciousness from propofol. Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):E1142-51. doi: 10.1073/pnas.1221180110. Epub 2013 Mar 4. PMID: 23487781; PMCID: PMC3607036.
Mashour GA. Anesthesia and the neurobiology of consciousness. Neuron. 2024 May 15;112(10):1553-1567. doi: 10.1016/j.neuron.2024.03.002. Epub 2024 Apr 4. PMID: 38579714; PMCID: PMC11098701.
Alkire MT, Hudetz AG, Tononi G. Consciousness and anesthesia. Science. 2008 Nov 7;322(5903):876-80. doi: 10.1126/science.1149213. PMID: 18988836; PMCID: PMC2743249.
Franks NP. General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal. Nat Rev Neurosci. 2008 May;9(5):370-86. doi: 10.1038/nrn2372. PMID: 18425091.
Franks NP, Zecharia AY. Sleep and general anesthesia. Can J Anaesth. 2011 Feb;58(2):139-48. doi: 10.1007/s12630-010-9420-3. Epub 2010 Dec 18. PMID: 21170623.
Mashour GA, Palanca BJ, Basner M, Li D, Wang W, Blain-Moraes S, Lin N, Maier K, Muench M, Tarnal V, Vanini G, Ochroch EA, Hogg R, Schwartz M, Maybrier H, Hardie R, Janke E, Golmirzaie G, Picton P, McKinstry-Wu AR, Avidan MS, Kelz MB. Recovery of consciousness and cognition after general anesthesia in humans. Elife. 2021 May 10;10:e59525. doi: 10.7554/eLife.59525. PMID: 33970101; PMCID: PMC8163502.
Share this post Facebook Bluesky Linkedin Email
There was a problem adding your email address. Please try again.
By submitting your information you agree to the Psychology Today Terms & Conditions and Privacy Policy
Mark S. Gold, M.D., is a pioneering researcher, professor, and chairman of psychiatry at Yale, the University of Florida, and Washington University in St Louis.
Get the help you need from a therapist near you–a FREE service from Psychology Today.
This article is part of the Bringwise Psychology Journal — daily insights on human behavior, mental health, and personal growth.